世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のL-カルノシン市場調査報告書2022年版

世界のL-カルノシン市場調査報告書2022年版


Global L-Carnosine Market Research Report 2022

COVID-19の大流行により、L-Carnosineの世界市場規模は2022年に2560万米ドル相当と推定され、2028年には3348万米ドルに再調整され、予測期間2022-2028年のCAGRは4.57%と予測されています。この健康危機による経済... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2022年7月12日 US$2,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

COVID-19の大流行により、L-Carnosineの世界市場規模は2022年に2560万米ドル相当と推定され、2028年には3348万米ドルに再調整され、予測期間2022-2028年のCAGRは4.57%と予測されています。この健康危機による経済変化を十分に考慮し、2021年にL-カルノシンの世界市場の94%を占める純度鈮99%は、2028年までに3192万米ドルの価値を持ち、2022年から2028年まで改訂4.78%のCAGRで成長すると予測されます。一方、栄養補助食品部門は、この予測期間を通して3.95%のCAGRに変更されています。

北米のL-カルノシンの市場規模は2021年に377万米ドル、ヨーロッパは557万米ドルでした。2021年の北米の割合は14.94%、ヨーロッパの割合は22.06%で、ヨーロッパ市場のシェアは2028年に21.45%に達し、分析期間を通じてCAGR4.22%をたどることが予測されます。アジアでは、日本と韓国が注目され、今後6年間のCAGRはそれぞれ4.08%と4.8%となる。
L-カルノシンの世界的な主要メーカーは、Fushilai Pharmaceutical、Hamari Chemicals、Wuhan BJM Pharm Inc.、Hubei Huntide Biotech Co.,Ltd 、Jiangsu Chengxin Pharmaceutical Co., Ltd、Belle Chemical、KS-V Peptide、Bachem、Suzhou Tianma Pharmaceuticalなど。収益面では、2021年のL-カルノシンの市場シェアは世界3大企業が70.85%を占めています。
本レポートは、世界レベル、地域レベル、企業レベルでのL-Carnosineの数量と価値に焦点を当てています。グローバルな視点から、過去のデータと将来の見通しを分析し、L-カルノシンの全体的な市場規模を表現しています。地域的には、このレポートはいくつかの主要な地域に焦点を当てています。北米、欧州、中国、日本、その他。

L-カルノシンの世界市場。セグメント分析
この調査レポートは、地域(国)別、企業別、タイプ別、用途別の具体的なセグメントを含んでいます。この調査では、2017年から2028年までの歴史的期間と予測期間における売上高と収益に関する情報を提供しています。セグメントを理解することは、市場の成長を助ける様々な要因の重要性を特定するのに役立ちます。

世界のL-カルノシン市場セグメント分析
この調査レポートは、地域(国)別、メーカー別、タイプ別、用途別の具体的なセグメントを含んでいます。各タイプは、2017年から2028年の予測期間中の生産に関する情報を提供します。アプリケーション別セグメントはまた、2017年から2028年の予測期間中の消費量を提供します。セグメントを理解することは、市場の成長を助けるさまざまな要因の重要性を特定するのに役立ちます。

企業別
フシライ製薬
ハマリケミカルズ
武漢BJMファーム株式会社
湖北瀚特生物科技有限公司
江蘇成新薬業有限公司
ベルケミカル
KS-Vペプチド
バケム
蘇州天馬製薬

種類別セグメント
純度922%以上
純度922%以上
用途別セグメント
健康補助食品
医薬品
化粧品・パーソナルケア

地域別消費量
北アメリカ
米国
カナダ
メキシコ
アジア・パシフィック
中国
日本
韓国
インド
オーストラリア
東南アジア
その他
欧州
ドイツ
フランス
英国
イタリア
スペイン
その他
南米
ブラジル
その他
中近東・アフリカ
中近東
アフリカ



ページTOPに戻る


目次

1 L-Carnosine Market Overview 1
1.1 Product Overview and Scope of L-Carnosine 1
1.2 L-Carnosine Segment by Type 1
1.2.1 Global L-Carnosine Sales Growth Rate Comparison by Type (2022-2028) 2
1.2.2 Purity 鈮98% 3
1.2.3 Purity 鈮99% 3
1.3 L-Carnosine Segment by Application 4
1.3.1 Global L-Carnosine Sales Comparison by Application (2022-2028) 4
1.3.2 Dietary Supplements 6
1.3.3 Pharmaceutical 7
1.3.4 Cosmetics and Personal Care 8
1.4 Global L-Carnosine Market Size Estimates and Forecasts 9
1.4.1 Global L-Carnosine Revenue 2017-2028 9
1.4.2 Global L-Carnosine Sales 2017-2028 10
1.4.3 L-Carnosine Market Size by Region: 2017 Versus 2021 Versus 2028 11
2 L-Carnosine Market Competition by Manufacturers 12
2.1 Global L-Carnosine Sales Market Share by Manufacturers (2017-2022) 12
2.2 Global L-Carnosine Revenue Market Share by Manufacturers (2017-2022) 15
2.3 Global L-Carnosine Average Price by Manufacturers (2017-2022) 16
2.4 Manufacturers L-Carnosine Manufacturing Sites, Area Served, Product Type 17
2.5 L-Carnosine Market Competitive Situation and Trends 18
2.5.1 L-Carnosine Market Concentration Rate 18
2.5.2 The Global 3 and 5 Largest L-Carnosine Players Market Share by Revenue 19
2.5.3 Global L-Carnosine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 19
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 20
3 L-Carnosine Retrospective Market Scenario by Region 21
3.1 Global L-Carnosine Retrospective Market Scenario in Sales by Region: 2017-2022 21
3.2 Global L-Carnosine Retrospective Market Scenario in Revenue by Region: 2017-2022 22
3.3 North America L-Carnosine Market Facts & Figures by Country 22
3.3.1 North America L-Carnosine Sales by Country 22
3.3.2 North America L-Carnosine Revenue by Country 23
3.3.3 United States 24
3.3.4 Canada 25
3.3.5 Mexico 25
3.4 Europe L-Carnosine Market Facts & Figures by Country 26
3.4.1 Europe L-Carnosine Sales by Country 26
3.4.2 Europe L-Carnosine Revenue by Country 27
3.4.3 Germany 28
3.4.4 France 29
3.4.5 UK 29
3.4.6 Italy 30
3.4.7 Spain 30
3.5 Asia Pacific L-Carnosine Market Facts & Figures by Region 31
3.5.1 Asia Pacific L-Carnosine Sales by Region 31
3.5.2 Asia Pacific L-Carnosine Revenue by Region 32
3.5.3 China 33
3.5.4 Japan 34
3.5.5 South Korea 34
3.5.6 India 35
3.5.7 Australia 35
3.5.8 SEA 36
3.6 South America L-Carnosine Market Facts & Figures by Country 36
3.6.1 South America L-Carnosine Sales by Country 36
3.6.2 South America L-Carnosine Revenue by Country 37
3.6.3 Brazil 38
3.7 Middle East and Africa L-Carnosine Market Facts & Figures by Country 38
3.7.1 Middle East and Africa L-Carnosine Sales by Country 38
3.7.2 Middle East and Africa L-Carnosine Revenue by Country 39
3.7.3 Middle East 40
3.7.4 Africa 40
4 L-Carnosine Historic Market Analysis by Type 41
4.1 Global L-Carnosine Sales Market Share by Type (2017-2022) 41
4.2 Global L-Carnosine Revenue Market Share by Type (2017-2022) 42
4.3 Global L-Carnosine Price by Type (2017-2022) 43
5 L-Carnosine Historic Market Analysis by Application 44
5.1 Global L-Carnosine Sales Market Share by Application (2017-2022) 44
5.2 Global L-Carnosine Revenue Market Share by Application (2017-2022) 45
5.3 Global L-Carnosine Price by Application (2017-2022) 46
6 Key Companies Profiled 47
6.1 Fushilai Pharmaceutical 47
6.1.1 Fushilai Pharmaceutical Corporation Information 47
6.1.2 Fushilai Pharmaceutical Description and Business Overview 47
6.1.3 Fushilai Pharmaceutical L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 48
6.1.4 Fushilai Pharmaceutical L-Carnosine Product Portfolio 48
6.2 Hamari Chemicals 50
6.2.1 Hamari Chemicals Corporation Information 50
6.2.2 Hamari Chemicals Description and Business Overview 50
6.2.3 Hamari Chemicals L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 51
6.2.4 Hamari Chemicals L-Carnosine Product Portfolio 51
6.3 Wuhan BJM Pharm Inc. 53
6.3.1 Wuhan BJM Pharm Inc. Corporation Information 53
6.3.2 Wuhan BJM Pharm Inc. Description and Business Overview 53
6.3.3 Wuhan BJM Pharm Inc. L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 54
6.3.4 Wuhan BJM Pharm Inc. L-Carnosine Product Portfolio 54
6.4 Hubei Huntide Biotech Co.,Ltd 55
6.4.1 Hubei Huntide Biotech Co.,Ltd Corporation Information 55
6.4.2 Hubei Huntide Biotech Co.,Ltd Description and Business Overview 55
6.4.3 Hubei Huntide Biotech Co.,Ltd L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 56
6.4.4 Hubei Huntide Biotech Co.,Ltd L-Carnosine Product Portfolio 56
6.5 Jiangsu Chengxin Pharmaceutical Co., Ltd 57
6.5.1 Jiangsu Chengxin Pharmaceutical Co., Ltd Corporation Information 57
6.5.2 Jiangsu Chengxin Pharmaceutical Co., Ltd Description and Business Overview 57
6.5.3 Jiangsu Chengxin Pharmaceutical Co., Ltd L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 58
6.5.4 Jiangsu Chengxin Pharmaceutical Co., Ltd L-Carnosine Product Portfolio 58
6.6 Belle Chemical 60
6.6.1 Belle Chemical Corporation Information 60
6.6.2 Belle Chemical Description and Business Overview 60
6.6.3 Belle Chemical L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 60
6.6.4 Belle Chemical L-Carnosine Product Portfolio 61
6.7 KS-V Peptide 61
6.7.1 KS-V Peptide Corporation Information 61
6.7.2 KS-V Peptide Description and Business Overview 62
6.7.3 KS-V Peptide L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 62
6.7.4 KS-V Peptide L-Carnosine Product Portfolio 63
6.8 Bachem 63
6.8.1 Bachem Corporation Information 63
6.8.2 Bachem Description and Business Overview 64
6.8.3 Bachem L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 64
6.8.4 Bachem L-Carnosine Product Portfolio 64
6.9 Suzhou Tianma Pharmaceutical 65
6.9.1 Suzhou Tianma Pharmaceutical Corporation Information 65
6.9.2 Suzhou Tianma Pharmaceutical Description and Business Overview 65
6.9.3 Suzhou Tianma Pharmaceutical L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 66
6.9.4 Suzhou Tianma Pharmaceutical L-Carnosine Product Portfolio 66
7 L-Carnosine Manufacturing Cost Analysis 67
7.1 L-Carnosine Key Raw Materials Analysis 67
7.1.1 Key Raw Materials 67
7.1.2 Key Suppliers of Raw Materials 67
7.2 Key Raw Materials Price (2018-2021) 68
7.3 L-Carnosine Industrial Chain Analysis 69
8 Marketing Channel, Distributors and Customers 70
8.1 Marketing Channel 70
8.2 L-Carnosine Distributors List 71
8.3 L-Carnosine Customers 72
9 L-Carnosine Market Dynamics 73
9.1 L-Carnosine Industry Trends 73
9.2 L-Carnosine Market Drivers 73
9.3 L-Carnosine Market Challenges 74
9.4 L-Carnosine Market Restraints 74
10 Global Market Forecast 75
10.1 L-Carnosine Market Estimates and Projections by Type 75
10.1.1 Global Forecasted Sales of L-Carnosine by Type (2023-2028) 75
10.1.2 Global Forecasted Revenue of L-Carnosine by Type (2023-2028) 75
10.2 L-Carnosine Market Estimates and Projections by Application 76
10.2.1 Global Forecasted Sales of L-Carnosine by Application (2023-2028) 76
10.2.2 Global Forecasted Revenue of L-Carnosine by Application (2023-2028) 76
10.3 L-Carnosine Market Estimates and Projections by Region 77
10.3.1 Global Forecasted Sales of L-Carnosine by Region (2023-2028) 77
10.3.2 Global Forecasted Revenue of L-Carnosine by Region (2023-2028) 78
11 Research Findings and Conclusion 79
12 Methodology and Data Source 80
12.1 Methodology/Research Approach 80
12.1.1 Research Programs/Design 80
12.1.2 Market Size Estimation 81
12.1.3 Market Breakdown and Data Triangulation 82
12.2 Data Source 83
12.2.1 Secondary Sources 83
12.2.2 Primary Sources 84
12.3 Author List 86
12.4 Disclaimer 86

 

ページTOPに戻る


 

Summary

Due to the COVID-19 pandemic, the global L-Carnosine market size is estimated to be worth US$ 25.60 million in 2022 and is forecast to a readjusted size of US$ 33.48 million by 2028 with a CAGR of 4.57% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity 鈮99% accounting for 94% of the L-Carnosine global market in 2021, is projected to value US$ 31.92 million by 2028, growing at a revised 4.78% CAGR from 2022 to 2028. While Dietary Supplements segment is altered to an 3.95% CAGR throughout this forecast period.

North America L-Carnosine market size was US$ 3.77 million in 2021, while Europe was US$ 5.57 million. The proportion of the North America was 14.94% in 2021, while Europe's percentage was 22.06%, and it is predicted that Europe market share will reach 21.45% in 2028, trailing a CAGR of 4.22% through the analysis period. As for the Asia, the notable markets are Japan and South Korea, CAGR is 4.08% and 4.8% respectively for the next 6-year period.
The global major manufacturers of L-Carnosine include Fushilai Pharmaceutical, Hamari Chemicals, Wuhan BJM Pharm Inc., Hubei Huntide Biotech Co.,Ltd, Jiangsu Chengxin Pharmaceutical Co., Ltd, Belle Chemical, KS-V Peptide, Bachem, and Suzhou Tianma Pharmaceutical, etc. In terms of revenue, the global three largest players hold a 70.85% market share of L-Carnosine in 2021.
This report focuses on L-Carnosine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall L-Carnosine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, etc.

Global L-Carnosine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Global L-Carnosine Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Company
Fushilai Pharmaceutical
Hamari Chemicals
Wuhan BJM Pharm Inc.
Hubei Huntide Biotech Co.,Ltd
Jiangsu Chengxin Pharmaceutical Co., Ltd
Belle Chemical
KS-V Peptide
Bachem
Suzhou Tianma Pharmaceutical

Segment by Type
Purity 鈮98%
Purity 鈮99%
Segment by Application
Dietary Supplements
Pharmaceutical
Cosmetics and Personal Care

Consumption by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Others
Europe
Germany
France
U.K.
Italy
Spain
Others
South America
Brazil
Others
Middle East and Africa
Middle East
Africa



ページTOPに戻る


Table of Contents

1 L-Carnosine Market Overview 1
1.1 Product Overview and Scope of L-Carnosine 1
1.2 L-Carnosine Segment by Type 1
1.2.1 Global L-Carnosine Sales Growth Rate Comparison by Type (2022-2028) 2
1.2.2 Purity 鈮98% 3
1.2.3 Purity 鈮99% 3
1.3 L-Carnosine Segment by Application 4
1.3.1 Global L-Carnosine Sales Comparison by Application (2022-2028) 4
1.3.2 Dietary Supplements 6
1.3.3 Pharmaceutical 7
1.3.4 Cosmetics and Personal Care 8
1.4 Global L-Carnosine Market Size Estimates and Forecasts 9
1.4.1 Global L-Carnosine Revenue 2017-2028 9
1.4.2 Global L-Carnosine Sales 2017-2028 10
1.4.3 L-Carnosine Market Size by Region: 2017 Versus 2021 Versus 2028 11
2 L-Carnosine Market Competition by Manufacturers 12
2.1 Global L-Carnosine Sales Market Share by Manufacturers (2017-2022) 12
2.2 Global L-Carnosine Revenue Market Share by Manufacturers (2017-2022) 15
2.3 Global L-Carnosine Average Price by Manufacturers (2017-2022) 16
2.4 Manufacturers L-Carnosine Manufacturing Sites, Area Served, Product Type 17
2.5 L-Carnosine Market Competitive Situation and Trends 18
2.5.1 L-Carnosine Market Concentration Rate 18
2.5.2 The Global 3 and 5 Largest L-Carnosine Players Market Share by Revenue 19
2.5.3 Global L-Carnosine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 19
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 20
3 L-Carnosine Retrospective Market Scenario by Region 21
3.1 Global L-Carnosine Retrospective Market Scenario in Sales by Region: 2017-2022 21
3.2 Global L-Carnosine Retrospective Market Scenario in Revenue by Region: 2017-2022 22
3.3 North America L-Carnosine Market Facts & Figures by Country 22
3.3.1 North America L-Carnosine Sales by Country 22
3.3.2 North America L-Carnosine Revenue by Country 23
3.3.3 United States 24
3.3.4 Canada 25
3.3.5 Mexico 25
3.4 Europe L-Carnosine Market Facts & Figures by Country 26
3.4.1 Europe L-Carnosine Sales by Country 26
3.4.2 Europe L-Carnosine Revenue by Country 27
3.4.3 Germany 28
3.4.4 France 29
3.4.5 UK 29
3.4.6 Italy 30
3.4.7 Spain 30
3.5 Asia Pacific L-Carnosine Market Facts & Figures by Region 31
3.5.1 Asia Pacific L-Carnosine Sales by Region 31
3.5.2 Asia Pacific L-Carnosine Revenue by Region 32
3.5.3 China 33
3.5.4 Japan 34
3.5.5 South Korea 34
3.5.6 India 35
3.5.7 Australia 35
3.5.8 SEA 36
3.6 South America L-Carnosine Market Facts & Figures by Country 36
3.6.1 South America L-Carnosine Sales by Country 36
3.6.2 South America L-Carnosine Revenue by Country 37
3.6.3 Brazil 38
3.7 Middle East and Africa L-Carnosine Market Facts & Figures by Country 38
3.7.1 Middle East and Africa L-Carnosine Sales by Country 38
3.7.2 Middle East and Africa L-Carnosine Revenue by Country 39
3.7.3 Middle East 40
3.7.4 Africa 40
4 L-Carnosine Historic Market Analysis by Type 41
4.1 Global L-Carnosine Sales Market Share by Type (2017-2022) 41
4.2 Global L-Carnosine Revenue Market Share by Type (2017-2022) 42
4.3 Global L-Carnosine Price by Type (2017-2022) 43
5 L-Carnosine Historic Market Analysis by Application 44
5.1 Global L-Carnosine Sales Market Share by Application (2017-2022) 44
5.2 Global L-Carnosine Revenue Market Share by Application (2017-2022) 45
5.3 Global L-Carnosine Price by Application (2017-2022) 46
6 Key Companies Profiled 47
6.1 Fushilai Pharmaceutical 47
6.1.1 Fushilai Pharmaceutical Corporation Information 47
6.1.2 Fushilai Pharmaceutical Description and Business Overview 47
6.1.3 Fushilai Pharmaceutical L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 48
6.1.4 Fushilai Pharmaceutical L-Carnosine Product Portfolio 48
6.2 Hamari Chemicals 50
6.2.1 Hamari Chemicals Corporation Information 50
6.2.2 Hamari Chemicals Description and Business Overview 50
6.2.3 Hamari Chemicals L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 51
6.2.4 Hamari Chemicals L-Carnosine Product Portfolio 51
6.3 Wuhan BJM Pharm Inc. 53
6.3.1 Wuhan BJM Pharm Inc. Corporation Information 53
6.3.2 Wuhan BJM Pharm Inc. Description and Business Overview 53
6.3.3 Wuhan BJM Pharm Inc. L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 54
6.3.4 Wuhan BJM Pharm Inc. L-Carnosine Product Portfolio 54
6.4 Hubei Huntide Biotech Co.,Ltd 55
6.4.1 Hubei Huntide Biotech Co.,Ltd Corporation Information 55
6.4.2 Hubei Huntide Biotech Co.,Ltd Description and Business Overview 55
6.4.3 Hubei Huntide Biotech Co.,Ltd L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 56
6.4.4 Hubei Huntide Biotech Co.,Ltd L-Carnosine Product Portfolio 56
6.5 Jiangsu Chengxin Pharmaceutical Co., Ltd 57
6.5.1 Jiangsu Chengxin Pharmaceutical Co., Ltd Corporation Information 57
6.5.2 Jiangsu Chengxin Pharmaceutical Co., Ltd Description and Business Overview 57
6.5.3 Jiangsu Chengxin Pharmaceutical Co., Ltd L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 58
6.5.4 Jiangsu Chengxin Pharmaceutical Co., Ltd L-Carnosine Product Portfolio 58
6.6 Belle Chemical 60
6.6.1 Belle Chemical Corporation Information 60
6.6.2 Belle Chemical Description and Business Overview 60
6.6.3 Belle Chemical L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 60
6.6.4 Belle Chemical L-Carnosine Product Portfolio 61
6.7 KS-V Peptide 61
6.7.1 KS-V Peptide Corporation Information 61
6.7.2 KS-V Peptide Description and Business Overview 62
6.7.3 KS-V Peptide L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 62
6.7.4 KS-V Peptide L-Carnosine Product Portfolio 63
6.8 Bachem 63
6.8.1 Bachem Corporation Information 63
6.8.2 Bachem Description and Business Overview 64
6.8.3 Bachem L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 64
6.8.4 Bachem L-Carnosine Product Portfolio 64
6.9 Suzhou Tianma Pharmaceutical 65
6.9.1 Suzhou Tianma Pharmaceutical Corporation Information 65
6.9.2 Suzhou Tianma Pharmaceutical Description and Business Overview 65
6.9.3 Suzhou Tianma Pharmaceutical L-Carnosine Sales, Revenue and Gross Margin (2017-2022) 66
6.9.4 Suzhou Tianma Pharmaceutical L-Carnosine Product Portfolio 66
7 L-Carnosine Manufacturing Cost Analysis 67
7.1 L-Carnosine Key Raw Materials Analysis 67
7.1.1 Key Raw Materials 67
7.1.2 Key Suppliers of Raw Materials 67
7.2 Key Raw Materials Price (2018-2021) 68
7.3 L-Carnosine Industrial Chain Analysis 69
8 Marketing Channel, Distributors and Customers 70
8.1 Marketing Channel 70
8.2 L-Carnosine Distributors List 71
8.3 L-Carnosine Customers 72
9 L-Carnosine Market Dynamics 73
9.1 L-Carnosine Industry Trends 73
9.2 L-Carnosine Market Drivers 73
9.3 L-Carnosine Market Challenges 74
9.4 L-Carnosine Market Restraints 74
10 Global Market Forecast 75
10.1 L-Carnosine Market Estimates and Projections by Type 75
10.1.1 Global Forecasted Sales of L-Carnosine by Type (2023-2028) 75
10.1.2 Global Forecasted Revenue of L-Carnosine by Type (2023-2028) 75
10.2 L-Carnosine Market Estimates and Projections by Application 76
10.2.1 Global Forecasted Sales of L-Carnosine by Application (2023-2028) 76
10.2.2 Global Forecasted Revenue of L-Carnosine by Application (2023-2028) 76
10.3 L-Carnosine Market Estimates and Projections by Region 77
10.3.1 Global Forecasted Sales of L-Carnosine by Region (2023-2028) 77
10.3.2 Global Forecasted Revenue of L-Carnosine by Region (2023-2028) 78
11 Research Findings and Conclusion 79
12 Methodology and Data Source 80
12.1 Methodology/Research Approach 80
12.1.1 Research Programs/Design 80
12.1.2 Market Size Estimation 81
12.1.3 Market Breakdown and Data Triangulation 82
12.2 Data Source 83
12.2.1 Secondary Sources 83
12.2.2 Primary Sources 84
12.3 Author List 86
12.4 Disclaimer 86

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

QYResearch社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630